Abstract: A process for producing an .alpha.,.beta.-unsaturated nitrile, the process comprising the step of: reacting (1) a hydrocarbon selected from an olefin selected from propylene and isobutylene, a paraffin selected from propane and butane, and tertiary butyl alcohol, (2) ammonia, and (3) an oxygen-containing gas, in a reactor at a high temperature in a gas phase over a fluidized bed, so as to prepare an .alpha.,.beta.-unsaturated nitrile having the same number of carbon atoms as the hydrocarbon as a starting material, the reactor comprising a reactor vessel having therein, from a bottom of the reactor vessel, an oxygen-containing gas dispersing plate or pipe and a mixed gas dispersing pipe for dispersing a mixed gas of the hydrocarbon and the ammonia, a pressure loss in the oxygen-containing gas dispersing plate or pipe is controlled to the range of from 0.6 to 3.0 times a pressure loss in the fluidized bed.

Abstract: Method and apparatus for making a fiber reinforced composite wherein fiber reinforcement material is disposed in a molding cavity formed between a substantially rigid molding tool and a compliant molding tool in a pressurizable chamber of a pressure vessel, such as an autoclave. Uncured polymer resin is introduced under pressure to the molding cavity by a resin pump disposed in the chamber or external thereof so as to initially infiltrate the fiber reinforcement material with the resin. The chamber is gas pressurized to provide isostatic pressure on the rigid and compliant tools during resin infiltration of the fiber reinforcement material. The resin-infiltrated fiber reinforcement material then is heated in the chamber to cure the resin matrix. Large surface area composites of the aerospace skin structure type can be made using the present invention.

Abstract: A process for preparing LiFeO.sub.2 having a layered rock salt type structure is characterized in that at least one member selected from the group consisting of water-soluble iron salts, iron hydroxides, iron oxide hydroxides, and metallic iron is subjected to a hydrothermal treatment in an aqueous solution containing lithium hydroxide and at least one of sodium hydroxide and potassium hydroxide at 130.degree. to 300.degree. C.

Abstract: The invention relates to a process for the preparation of carbonates having a six-membered ring, of the formula ##STR1## by transesterification of 1,3-propanediol compounds with carbonic acid esters and subsequent distillative depolymerization of the oligo- or polycarbonate initially formed, one or more catalysts from the group consisting of compounds of Sn, Ti or Zr being employed both for the transesterification and for the depolymerization and, if appropriate, the distillation residue is at least partly recycled into the transesterification. Such carbonates having a six-membered ring can furthermore be stabilized against undesirable polymerization by addition of small amounts of acids of sulfur or phosphorus or esters or salts thereof.

Abstract: The invention relates to new derivatives of acetylsalicylic acid (called ASA in the following), which contain an NO.sub.3 structure. They are therapeutically active either as the intact active compound molecule or after cleavage (NO release). The invention also relates to processes for their preparation and their use as medicaments, in particular for the alleviation of pain, inhibition of platelet aggregation, lowering of fever and for the prevention of cardiovascular disorders and oncoses.

Abstract: Compound of formula (I) are disclosed ##STR1## as well as optically active isomers or pharmacologically acceptable salts thereof. The compounds are useful active ingredients in pharmaceutical compositions, and methods of treating osteoporosis, inflammation or diseases which are due to thromboembolic events. Compounds of formula (II) are also disclosed ##STR2## which are useful as starting compounds for preparing compounds of formula (I).

Abstract: The present invention relates to a novel class of sulfonamides which are aspartyl protease inhibitors. In one embodiment, this invention relates to a novel class of HIV aspartyl protease inhibitors characterized by specific structural and physicochemical features. This invention also relates to pharmaceutical compositions comprising these compounds. The compounds and pharmaceutical compositions of this invention are particularly well suited for inhibiting HIV-1 and HIV-2 protease activity and consequently, may be advantageously used as anti-viral agents against the HIV-1 and HIV-2 viruses. This invention also relates to methods for inhibiting the activity of HIV aspartyl protease using the compounds of this invention and methods for screening compounds for anti-HIV activity.

Abstract: A lightweight multilayer heat reflective concrete cure blanket having a moisture-impervious top outer layer, a moisture impervious bottom outer layer, and the top and bottom layers sealingly connected to each other at the boundaries of the layers to form a moisture impervious chamber between the first and second layers. The chamber includes at least one insulative layer therein, and a heat reflective material is applied to an outer surface of the bottom layer to reflect heat emanating from the concrete when the blanket is placed over the concrete. A protective heat permeable layer is applied over the heat reflective material to protect the heat reflective material from chemicals and dirt in the concrete. In a further embodiment, a second heat reflective material is applied to an inner surface of the upper layer to reflect additional heat which radiates from the concrete through the insulative layer and back towards the concrete.

Abstract: The present invention relates to a process for the hydrocyanation of organic compounds containing ethylenic unsaturation to nitrites, in particular the hydrocyanation of diolefins or of substituted olefins, such as alkenenitriles.More specifically, it comprises a process for the hydrocyanation of organic compounds containing at least one ethylenic double bond by reaction with hydrogen cyanide in the presence of an aqueous solution of a catalyst comprising at least one transition metal compound and at least one water-soluble phosphine, characterized in that the said water-soluble phosphine is a monodentate or bidentate phosphine.

Abstract: The invention relates to the compounds having the structures I and II: ##STR1## The invention also relates to a method of making the compound having the structure I by mixing 2,2,4,4-tetramethyl-1,3-cyclobutanediol; dimethyl carbonate; and a basic catalyst, and heating the mixture.

Abstract: The process for manufacturing ascorbic acid 2-mono-phosphates from ascorbic acid 2-polyphosphates, in particular 2-triphosphates by subjecting the ascorbic acid 2-triphosphates to drying conditions.

Abstract: The present invention relates to a pyrazole derivative represented by formula (I) or (II) ##STR1## wherein R.sup.1 is hydrogen C2-C6 alkyl benzyl or phenyl; each of R.sup.2 and R.sup.3 is hydrogen, C1-C6 alkyl or benzyl; each of R.sup.4 and R.sup.5 is hydrogen, C1-C6 alkyl, C3-C6 alkenyl, C3-C8 cycloalkyl, benzyl or phenyl;X is oxygen or sulfur;R.sup.5 is hydrogen, C2-C6 alkyl, C3-C6 alkenyl, C3-C8 cycloalkyl or benzyl when R.sup.1 is benzyl, R.sup.2 is ethyl, R.sup.3 is hydrogen, and R.sup.4 is hydrogen, and its pharmaceutical use.

Abstract: A process for producing an asymmetric compound using a metal complex containing no rare earth metal element is disclosed. The process affords an optically active compound having high optical purity. Optically active binaphthol having the chemical formula ##STR1## and lithium aluminum hydride are reacted, or the optically active binaphthol, a dialkyl aluminum hydride, and a base containing an alkali metal (or a base containing alkaline earth metal) are reacted to prepare a metal complex comprising optically active binaphthol, aluminum, and alkali metal (or alkaline earth metal). This metal complex can be used as a catalyst to perform an asymmetric Michael reaction, an asymmetric phosphonylation reaction, or the like, to obtain, in a high yield, an asymmetric compound having high optical purity.

Abstract: The present invention provides a process for hydrocyanation comprising reacting a nonconjugated, ethylenically unsaturated compound in a two phase process solvent with HCN in the presence of a Lewis acid promoter and a catalyst system comprising zero-valent nickel and an organic phosphorous containing ligand having the structure (PR.sub.2).sub.n R' where n is an integer from 1 to 2, R and R' are organic residues which may be the same or different and where the R or R' contain at least one C9 to C40 aliphatic group positioned as a tail extending away from the primary ligand structure rendering the ligand lipophilic.

Abstract: A process for the enhanced recovery of hydrogen cyanide (HCN) obtained from the reactor effluent of an ammoxidation reaction of propylene or isobutylene comprising passing the reactor effluent through a quench column, an absorber column, a first distillation column, a second distillation column, a cooler and a knock-out pot, wherein the improvement comprises contacting the vapor phase containing hydrogen cyanide with an aqueous stream.

Abstract: A novel ketone derivative (I) which possesses a potent inhibitory activity against thiol protease such as papain, cathepsin B, cathepsin H, cathepsin L, calpain or the like with excellent properties regarding oral absorbance, tissue transference and cell membrane permeability, and are clinically useful in the treatment of various diseases such as muscular dystrophy, amyotrophy. Also provided are a process for producing the compound (I) and a pharmaceutical composition containing the same.

Abstract: The present invention relates to a process for selective dimerization of 2-pentenenitrile or mixtures of 2- and 3-pentenenitrile in the presence of a strong base to form 1,3-dicyano-2-ethyl-3-hexene.

Abstract: The present invention relates to a process for the preparation of pentenenitriles. In this process the 3- or 4-pentenenitriles are produced by reacting 2-methylglutarimide, ethylsuccinimide, and/or their precursors, such as 4-cyanovalerimide, 2-methyl-4-cyanobutyrimide, 4-cyanovaleric acid, 2-methyl-4-cyanobutyric acid, 3-cyanovalerimide, 2-ethyl-3-cyanopropionimide, 3-cyanovaleic acid, and 2-ethyl-3-cyanopropionic acid, in the vapor phase at temperatures of 200.degree. to 600.degree. C. in the presence of an acidic solid catalyst, such as acidic molecular sieves, acidic clays, bridged or pillared clays, bulk oxides, and acidic phosphates.

Abstract: 3-Amino-2-hydroxy-4-phenylbutyronitrile derivatives represented by the formula (3) may be prepared by reacting an aminoaldehyde derivative represented by the formula (1) with a cyanohydrin derivative represented by the formula (2) in the presence of a metallic compound, base, or acid; ##STR1## wherein R.sup.1 and R.sup.2 each independently represents a hydrogen atom or a protective group for an amino group, R.sup.3 and R.sup.4 each represents an alkyl or cycloalkyl group or R.sup.3 and R.sup.4 together form a tetramethylene or pentamethylene group.

Abstract: A process for the preparation of aminoacetic acids or aminoacetonitriles with a tertiary hydrocarbon radical in the .alpha.-position in which monoamide derivatives of malonic acid are subjected to a Hofmann rearrangement.